Drug Type Recombinant protein |
Synonyms- |
Target |
Action antagonists |
Mechanism CCR5 antagonists(C-C chemokine receptor type 5 antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Autoimmune Diseases | Preclinical | Israel | 09 Sep 2010 | |
| Autoimmune Diseases | Preclinical | Israel | 09 Sep 2010 |






